Cargando…

Correction: Li et al. Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter. Curr. Issues Mol. Biol. 2021, 43, 543–557

Detalles Bibliográficos
Autores principales:	Li, Jing, Haque, Moinul, Shang, Chuquan, Hassan, Bardes, Liu, Dongzhe, Chen, Will, Lai, Raymond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600741/ https://www.ncbi.nlm.nih.gov/pubmed/36286064 http://dx.doi.org/10.3390/cimb44100346

Ejemplares similares

Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter
por: Li, Jing, et al.
Publicado: (2021)

Crizotinib Resistance Mediated by Autophagy Is Higher in the Stem-Like Cell Subset in ALK-Positive Anaplastic Large Cell Lymphoma, and This Effect Is MYC-Dependent
por: Shang, Chuquan, et al.
Publicado: (2021)

Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma
por: Shang, Chuquan, et al.
Publicado: (2023)

Correction: Zhang et al. Parkin, as a Regulator, Participates in Arsenic Trioxide-Triggered Mitophagy in HeLa Cells. Curr. Issues Mol. Biol. 2022, 44, 2759–2771
por: Zhang, Zhewen, et al.
Publicado: (2023)

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
por: Haque, Moinul, et al.
Publicado: (2019)

Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126
por: Merchant, Hamid A.
Publicado: (2022)

Fungal Planet description sheets: 469–557
por: Crous, P.W., et al.
Publicado: (2016)

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
por: Stadler, Serena, et al.
Publicado: (2018)

Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
por: Wang, Yuan, et al.
Publicado: (2022)

Pathobiology of ALK-negative anaplastic large cell lymphoma
por: Pileri, Stefano A., et al.
Publicado: (2011)

ALK-positive anaplastic large cell lymphoma in adults
por: Gromowsky, Matthew J, et al.
Publicado: (2023)

Corrigendum to “Unraveling the mechanobiology of immune cells” [Curr Opin Biotechnol 66 (2020) 236-245]()
por: Zhang, Xuexiang, et al.
Publicado: (2022)

Amendment to Document ""Special Contribution"" (CERN/FC/557)
Publicado: (1962)

SAT557 Unexpected Whole Body Scan Finding
por: Gastelum, Alheli Arce, et al.
Publicado: (2023)

An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
por: Turner, Suzanne D.
Publicado: (2017)

Corrigendum to “A survey of pathways for mechano-electric coupling in the atria” [Prog. Biophys. Mol. Biol. 159 (January 2021) 136–145]
por: Varela, Marta, et al.
Publicado: (2022)

Atypical Carcinoid Tumor with Anaplastic Lymphoma Kinase (ALK) Rearrangement Successfully Treated by an ALK Inhibitor
por: Nakajima, Masayuki, et al.
Publicado: (2016)

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
por: van Erp, Anke E. M., et al.
Publicado: (2017)

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma
por: Tabbó, Fabrizio, et al.
Publicado: (2012)

Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
por: Satou, Akira, et al.
Publicado: (2020)

Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
por: Subbiah, V., et al.
Publicado: (2021)

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
por: Iwama, Eiji, et al.
Publicado: (2014)

Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells
por: Alam, Muhammad Wasi, et al.
Publicado: (2019)

Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels
por: Duijkers, Floor A. M., et al.
Publicado: (2011)

Office Hysteroscopy for Infertility: A Series of 557 Consecutive Cases
por: Koskas, Martin, et al.
Publicado: (2010)

Correction to Lancet Rheumatol 2020; 2: e557–64
Publicado: (2021)

Séminaire Bourbaki : exposés 543-560
por: Dold, A, et al.
Publicado: (1981)

543 Diversity in Burn Surgery Programs
por: Delapena, Samantha, et al.
Publicado: (2023)

From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
por: Werner, Michael T., et al.
Publicado: (2017)

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma
por: Singh, Vijay Kumar, et al.
Publicado: (2019)

Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
por: Zdzalik, Daria, et al.
Publicado: (2014)

Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
por: Krishnamurthy, Savitri, et al.
Publicado: (2013)

ALK-positive anaplastic large cell lymphoma that presented as pleural effusion
por: Kim, Do Hwan, et al.
Publicado: (2022)

ALK-Positive Anaplastic Large Cell Lymphoma Associated With Hemophagocytic Lymphohistiocytosis
por: Chao, Shing, et al.
Publicado: (2023)

SUN-557 Thymic Hyperplasia in Graves' Disease: A Case Series
por: Voss, Michael, et al.
Publicado: (2019)

Whole-Genome Sequence of Streptomyces kaniharaensis Shomura and Niida SF-557
por: Zhu, Wen, et al.
Publicado: (2020)

POS-557 COVID-19 IN HEMODIALYSIS PATIENTS: CLINICAL PARTICULARITIES AND OUTCOMES
por: BEN ACHOUR, N., et al.
Publicado: (2022)

557. Trends in Remdesivir Treatment Over the Course of the COVID-19 Pandemic
por: Xin Liao, J, et al.
Publicado: (2021)

557 Introduction of a Pediatric Burn Education Program in an Adult Hospital
por: Snyder, Emily
Publicado: (2022)

MicroRNA-543 controls pancreatic cancer development by LINC00847-microRNA-543-STK31 axis
por: Liu, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tn99t147vod949cd1h6lfsuk11